Mobile-health Network Solutions Reports Improved Gross Margin and Cash Position, Reduced Operating Expenses, in H1 FY2026
MWN-AI** Summary
Mobile-health Network Solutions (NASDAQ: MNDR), a leading AI HealthTech platform, reported robust financial improvements for the first half of fiscal 2026, which ended on December 31, 2025. The company achieved a gross margin of 20.1%, a notable increase from 14.8% in H1 FY2025, primarily attributed to a 13.8% reduction in the cost of revenue. This shift resulted in a 25.3% rise in gross profit year-over-year. MNDR's cash reserves jumped to $3.48 million, up from $1.03 million at the end of the previous fiscal period, bolstered by enhanced operational efficiencies and recent fundraising efforts.
Total operating expenses for the half-year fell significantly to $1.67 million, down 29.9% from $2.38 million the previous year. This decrease was largely due to the accelerated implementation of AI technologies, including automated scheduling and predictive maintenance, leading to lower salaries and other operating costs. As a result, the company reported a net loss of $0.86 million, a substantial 48.2% reduction from the prior year’s loss of $1.66 million.
CEO Dr. Siaw Tung Yeng expressed optimism about these early fiscal results, emphasizing the role of AI in streamlining operations while maintaining service quality. Looking ahead, MNDR aims to further deploy AI across various areas including predictive maintenance and automation, while focusing on disciplined capital management. The strategy includes reinvesting cost savings into sales growth and product development, particularly through the adoption of Otter.SG, a cutting-edge AI-native Clinic Operating System. With plans for continued expansion within Southeast Asia and into the US market, MNDR positions itself as a transformative player in the digital health landscape.
MWN-AI** Analysis
**Market Analysis and Advice for Mobile-health Network Solutions (NASDAQ: MNDR)**
Mobile-health Network Solutions (MNDR) recently reported substantial progress in its financial performance for the first half of fiscal 2026. With a gross margin soaring to 20.1% from 14.8% the previous year, and a notable net loss reduction of 48.2% to $0.86 million, the company's commitment to optimizing operational efficiencies is clear. These improvements stem largely from the successful deployment of AI technologies which not only enhance service delivery but also significantly cut operational costs.
The rise in cash reserves from $1.03 million to $3.48 million indicates that MNDR is stabilizing its financial footing, enabling strategic investments in AI and growth initiatives. A frugal operating expense profile, down nearly 30%, suggests prudent management and a strong focus on maintaining a lean operational model. This is especially crucial in the evolving healthcare landscape, where agility can drive competitive advantage.
Looking forward, MNDR’s strategy centers around reinforcing their AI capabilities, increasing automation, and potentially growing by capitalizing on the recent advancements in telemedicine. The introduction of the Otter.SG AI-native Clinic Operating System represents a strategic shift toward an asset-light, software-driven model, which could enhance scalability.
For investors, this report paints a favorable picture of MNDR's operational resilience, offering potential upside if these positive trends continue. However, it is essential to remain cautious of the competitive landscape and regulatory challenges in the health-tech sector. Predicted demand for telehealth solutions, especially in Southeast Asia and the U.S., could bolster MNDR's market position but requires vigilant management.
In summary, MNDR presents an intriguing opportunity for growth-oriented investors. The company's solid financial improvements, along with a clear strategic focus on AI deployment and operational efficiency, position it well for future success. Nonetheless, potential investors should weigh the risks of technological competition and market dynamics before committing capital.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Singapore, Singapore--(Newsfile Corp. - March 12, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or "the Company"), a leading AI HealthTech platform, today announced that, for the first six months of fiscal 2026 ended December 31, 2025, the Company achieved significant improvements in its gross margin and cash position while slashing its total operating expenses and net loss.
Gross margin for the first half of fiscal 2026 was 20.1 percent, compared with 14.8 percent for the first half of fiscal 2025. This improvement was mainly the result of a 13.8 percent reduction in cost of revenue, which led to a 25.3 percent increase in gross profit compared to the first half of fiscal 2025.
Net cash and cash equivalents at December 31, 2025, rose to $3.48 million, compared with $1.03 million at June 30, 2025. This increase, driven by operational efficiency gains and fundraising, is expected to help facilitate continued investment in AI and selective growth initiatives.
Total operating expenses for 1H FY 2026 were $1.67 million, a 29.9 percent reduction compared with $2.38 million in the year-ago period. This improvement was primarily driven by the accelerated deployment of AI-enabled scheduling, predictive maintenance, and automated administrative workflows, which reduced salaries and benefits and other operating costs.
The Company's net loss for the first six months of fiscal 2026 was $0.86 million, a 48.2 percent decrease from the net loss of $1.66 million sustained in the first half of fiscal 2025. This improvement was mainly due to the Company's reduction in total operating expenses.
"We are excited about the progress we have made in the first half of fiscal 2026," said the Chief Executive Officer, Dr. Siaw Tung Yeng, "By embedding AI into our core operations, we have achieved significant savings and better operating results while preserving the quality of our services."
Going forward, said Dr. Siaw, the Company's strategic priorities will include:
- Continue AI deployment. Expand predictive maintenance, intelligent rostering, automated documentation, and analytics across additional contracts to drive further cost savings;
- Protect and improve service quality. Combine automation with targeted employee upskilling to deliver higher-value service to customers;
- Maintain disciplined capital management. Preserve liquidity while prioritizing high-ROI AI projects and scalable SaaS initiatives; and
- Reinvest selectively. Allocate a portion of the cost savings to sales expansion, product enhancements, and adoption of Otter.SG, an AI-native Clinic Operating System, unifying clinical, operational, and financial workflows and helping accelerate the Company's transition to an asset-light, software-enabled model.
Financial snapshot (six months ended December 31, 2025; unaudited)
- Revenue: US$3,948,768
- Gross profit: US$795,303
- Total operating expenses: US$1,672,590
- Net loss: US$858,417
- Cash and cash equivalents: US$3,479,487
- Net tangible assets (NTA): US$8,326,619
- NTA per share: US$2.61 (rounded)
About Mobile-health Network Solutions
Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website.
Forward-Looking Statements
Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law.
For media inquiries, please contact:
Mobile-health Network Solutions Investor Relations Contact:
2 Venture Drive, #07-08 Vision Exchange
Singapore 608526
(+65) 6222 5223
Email: investors@manadr.com
Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: ir@skylineccg.com
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288253
FAQ**
How is Mobile-health Network Solutions MNDR planning to expand its AI deployment in Singapore's healthcare sector amid rising operational efficiency and improved service quality?
What factors contributed to the significant improvement in Mobile-health Network Solutions MNDR's gross margin and cash position for the first six months of fiscal 20in Singapore?
In what ways does Mobile-health Network Solutions MNDR plan to invest selectively in growth initiatives while maintaining disciplined capital management in Singapore's competitive HealthTech market?
How does the performance of Mobile-health Network Solutions MNDR in Singapore compare to its operations in Southeast Asia and the US, particularly regarding telehealth solutions?
**MWN-AI FAQ is based on asking OpenAI questions about Mobile-health Network Solutions (NASDAQ: MNDR).
NASDAQ: MNDR
MNDR Trading
-4.17% G/L:
$3.105 Last:
2,930 Volume:
$3.20 Open:
MNDR Latest News
